Clinical Trial Update: Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hypofractionated vs normofractionated IMRT for breast cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Tumors, Breast Cancer | Phase 3 | Status: COMPLETED